Horus’ VECTrans® platform to deliver Servier’s oligonucleotides to the brain for the treatment of rare neurological and ...

Appointment further strengthens Vect-Horus’ leadership as company continues growth and development Marseille, France, March 10, 2026 - Vect-Horus, a privately held biotechnology company that designs ...

C-Suite executive with more than 35 years’ experience in international banking Brings important and complementary skills to support company’s development Marseille, France, April 24, 2025 - Vect-Horus ...

MARSEILLE, France--(BUSINESS WIRE)--VECT-HORUS, a biotech company that designs and develops vectors that enable therapeutic molecules or imaging agents to be delivered to key organs, has just closed ...

The latest variant of an emerging ransomware may be far more destructive than its operators intended, acting as a wiper that deletes many of an organization's captured files instead of encrypting them ...

Brings extensive experience in investor relations and financial research and analysis Will drive financial strategy to support internal pipeline and partnerships Marseille, France, March 25, 2025 - ...

MARSEILLE, France--(BUSINESS WIRE)--Vect-Horus, a privately held biotechnology company that designs and develops vectors that facilitate the targeted delivery of therapeutic molecules and imaging ...

If newbie to the ransomware scene VECT comes knocking at your organisation's door – do not pay the ransom! That's the call from researchers at leading global cyber security firm Check Point, which has ...

Vect 2.0 ransomware has been found to wipes large, compromised files instead of merely encrypting them, making recovery impossible – even for the attackers. This is due to a critical flaw in the ...